推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Cancers 期刊收藏夹

欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此反馈;如有合作推广需求,请点此洽谈

按期刊名首写字母查看 CANCERS最新评论:2025年不是了 (2025-03-19)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
近期推荐:
SCI论文AI润色+人工QC服务
同行专家帮助选刊
Springer Nature特刊征稿
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Cancers期刊基本信息Hello,您是该期刊的第239079位访客

基本信息 登录收藏
期刊名字CancersCancers

CANCERS
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.6
59人评分
我要评分

声誉
8.3

影响力
6.8

速度
9.5

期刊ISSN2072-6694
蝌蝌APP,让您与同行交流更轻松
立即下载
2024-2025最新影响因子
(数据来源于搜索引擎)
4.4 点击查看影响因子趋势图
实时影响因子 截止2025年5月19日:4.319
2024-2025自引率6.80%点击查看自引率趋势图
五年影响因子4.8
JCI期刊引文指标 0.86
h-index 53
CiteScore
2025年最新版
CiteScoreSJRSNIPCiteScore排名
8.801.4621.114
学科分区排名百分位
大类:Medicine
小类:Oncology
Q168 / 415
大类:Medicine
小类:Cancer Research
Q259 / 233

期刊简介
Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
期刊官方网站https://www.mdpi.com/journal/cancers
期刊投稿格式模板
VIP专享
Word版格式模板  
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
 
期刊投稿网址https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue
期刊语言要求Language
To facilitate proper peer-reviewing of your manuscript, it is essential that it is submitted in grammatically correct English.
MDPI provides minor English editing by native English speakers for all accepted papers, included in the APC. The APC does not cover extensive English editing. Your paper could be returned to you at the English editing stage of the publication process if extensive editing is required. You may choose to use a paid language-editing service before submitting your paper for publication.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancers的语言要求,还能让Cancers编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancers编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( CHF2900; )
文章处理费豁免:没有
其他费用:没有
期刊主题关键词:oncology、tumours、cancer
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052
出版商MDPI (Basel, Switzerland)
涉及的研究方向Medicine-Oncology
出版国家或地区Switzerland
出版语言English
出版周期
出版年份2009
年文章数 4182点击查看年文章数趋势图
Gold OA文章占比99.96%
研究类文章占比:
文章 ÷(文章 + 综述)
65.16%
WOS期刊SCI分区
2024-2025年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ285/326
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ2104/326
中国科学院《国际期刊预警
名单(试行)》名单
2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:预警原因:引用操纵

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2025年3月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区3区1区
ONCOLOGY
肿瘤学
1区2区3区
中国科学院SCI期刊分区
2023年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区2区3区
ONCOLOGY
肿瘤学
3区2区3区
中国科学院SCI期刊分区
2022年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区2区
ONCOLOGY
肿瘤学
2区2区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2072-6694%5BISSN%5D
平均审稿速度期刊官网数据:
平均18.07天
网友分享经验:
11 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( CHF2900; )
文章处理费豁免:没有
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Cancers顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
提交文稿
期刊常用信息链接
同领域相关期刊 Cancers期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Cancers中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Cancers上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Nature Cancer034.20
    JAMA Oncology4132.60
    JAMA Oncology6132.60
    Trends in Cancer025.50
    Experimental Hematology & Oncology014.30
    Liver Cancer2519.50
    Cancer Biology & Medicine299.60
    ESMO Open012.40
    Annual Review of Cancer Biology06.60
    JNCI Cancer Spectrum07.50
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE743579
    BIOMATERIALS615814
    BIOMEDICINE & PHARMACOTHERAPY609019
    Frontiers in Pharmacology575766
    COMPUTERS IN BIOLOGY AND MEDICINE572019
    JOURNAL OF ETHNOPHARMACOLOGY567249
    Frontiers in Immunology563544
    Frontiers in Oncology504467
    COLLOIDS AND SURFACES B-BIOINTERFACES471844
    PHYTOMEDICINE469093
  •  

    Cancers Cancers
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Tumor Treating Fields and Combination Therapy in Management of Brain Oncology

    Author: Liu, Ruisi Nicole; Huang, James H.; Qi, Xiaoming; Pan, Yizhong; Wu, Erxi; Nizamutdinov, Damir
    Journal: CANCERS. 2025; Vol. 17, Issue 7, pp. -. DOI: 10.3390/cancers17071211
        PubMed      DOI
    2.Methotrexate Chemotherapy Causes Growth Impairments, Vitamin D Deficiency, Bone Loss, and Altered Intestinal Metabolism-Effects of Calcitriol Supplementation (vol 15, 4367, 2023)

    Author: Su, Yu-Wen; Lee, Alice M. C.; Xu, Xukang; Hua, Belinda; Tapp, Heather; Wen, Xue-Sen; Xian, Cory J.
    Journal: CANCERS. 2025; Vol. 17, Issue 7, pp. -. DOI: 10.3390/cancers17071207
        DOI
    3.ALDH1A3 Regulates Cellular Senescence and Senescence-Associated Secretome in Prostate Cancer

    Author: Wang, Sen; Wang, Lin; Zhao, Yu
    Journal: CANCERS. 2025; Vol. 17, Issue 7, pp. -. DOI: 10.3390/cancers17071184
        PubMed      DOI
    4.Estimating the Morbidity of Robot-Assisted Radical Cystectomy Using the Comprehensive Complication Index: Data from the Asian Robot-Assisted Radical Cystectomy Consortium

    Author: Yuanming, Alvin Lee; Na, Fiona Tan Bei; Tiwari, Raj; Chan, Thomas Kong Ngai; Teoh, Jeremy Yuen-Chun; Kang, Seok-Ho; Patel, Manish I.; Muto, Satoru; Yang, Cheng-Kuang; Hatakeyama, Shingo; Kijvikai, Kittinut; Chen, Haige; Ohyama, Chikara; Horie, Shigeo; Chan, Eddie Shu-Yin; Lee, Lui-Shiong
    Journal: CANCERS. 2025; Vol. 17, Issue 7, pp. -. DOI: 10.3390/cancers17071157
        PubMed      DOI
    5.Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database

    Author: Danpanichkul, Pojsakorn; Pang, Yanfang; Auttapracha, Thanida; Al Ta'ani, Omar; Suenghataiphorn, Thanathip; Kaewdech, Apichat; Muthiah, Mark D.; Kim, Donghee; Wijarnpreecha, Karn; Singal, Amit G.; Yang, Ju Dong
    Journal: CANCERS. 2025; Vol. 17, Issue 7, pp. -. DOI: 10.3390/cancers17071133
        PubMed      DOI
    6.Methylation-Mediated Silencing of miR-124-3 Regulates LRRC1 Expression and Promotes Oral Cancer Progression

    Author: Liao, Shin-Wei; Liao, Xiao-Hui; Wu, Shao-Huang; Li, Yu-Fen; Chen, Pin-Yi; Wang, Yi-Ling; Lu, Yin-Che; Tai, Chien-Kuo
    Journal: CANCERS. 2025; Vol. 17, Issue 7, pp. -. DOI: 10.3390/cancers17071136
        PubMed      DOI
    7.Reduced Taurine Synthesis Underlies Morphine-Promoted Lung Metastasis of Triple-Negative Breast Cancer

    Author: Chen, Shih-Hong; Ke, Ting-Ling; Shih, Chien-Hung; Hsiung, Chia-Ni; Chen, Kuo-Chin; Huang, Zi-Xuan; Chuang, Tsung-Hsien; Chen, Li-Kuei; Chen, Linyi
    Journal: CANCERS. 2025; Vol. 17, Issue 7, pp. -. DOI: 10.3390/cancers17071086
        PubMed      DOI
    8.GATA3-Driven ceRNA Network in Lung Adenocarcinoma Bone Metastasis Progression and Therapeutic Implications

    Author: Liu, Yun; Shen, Shihui; Wang, Xudong; Chen, Hansen; Ren, Wenjie; Wei, Haifeng; Li, Kun; Li, Lei
    Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030559
        PubMed      DOI
    9.Targeting Hepatocellular Carcinoma Growth: Haprolid's Inhibition of AKT Signaling Through DExH-Box Helicase 9 Downregulation

    Author: Xing, Jun; Feng, Xiaoxi; Zhang, Rutong; Zhang, Kaiguang
    Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030443
        PubMed      DOI
    10.Antibody-Drug Conjugates Targeting CD30 in T-Cell Lymphomas: Clinical Progression and Mechanism

    Author: Jiang, Yi; Dong, Sai; Wang, Yang
    Journal: CANCERS. 2025; Vol. 17, Issue 3, pp. -. DOI: 10.3390/cancers17030496
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    同分区等级的其他期刊名称 h-index CiteScore
    HemaSphere07.20
    COMMUNICATIONS OF THE ACM18914.30
    Wiley Interdisciplinary Reviews-Data Mining and Knowledge Discovery3121.70
    Journal of High Energy Astrophysics119.20
    Business & Information Systems Engineering018.60
    Business & Information Systems Engineering018.60
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY2114.80
    Battery Energy011.00
    Progress in Energy020.10
    CLINICAL NUCLEAR MEDICINE533.00
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共306


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2025 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室